Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes

Journal of Heart and Lung Transplantation

Volumn 34, Issue 5, 2015, Pages 685-692

  Alba, Ana C ^a   Tinckam, Kathryn ^a   Foroutan, Farid ^a   Nelson, Laerke M ^b   Gustafsson, Finn ^b   DMSci, Kam Sander ^b   DMSci, Hellen Bruunsgaard ^b   Chih, Sharon ^c   Hayes, Helen ^c   Rao, Vivek ^a   Delgado, Diego ^a   Ross, Heather J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Advanced heart failure; Human leukocyte antigen; Panel reactive antibodies; Transplant outcomes; Ventricular assist device therapy

Indexed keywords

FRESH FROZEN PLASMA; HLA ANTIBODY; PANEL REACTIVE ANTIBODY; HLA ANTIGEN;

ARTICLE; ARTIFICIAL VENTILATION; CARDIAC GRAFT REJECTION; COHORT ANALYSIS; DEATH; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GRAFT FAILURE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STERNOTOMY; THROMBOCYTE TRANSFUSION; ADOLESCENT; ADULT; ADVERSE EFFECTS; AGED; AUSTRALIA; CANADA; CLINICAL TRIAL; EPIDEMIOLOGY; GRAFT REJECTION; GRAFT SURVIVAL; HEART ASSIST DEVICE; IMMUNOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; SURVIVAL RATE; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; ONTARIO; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84933183050     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.11.024     Document Type: Article

References (42)

1. Hunt SA, Antman EM, Smith SC, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure), developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation, endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
2. Goodlin SJ, Hauptam PJ, Arnold R, et al. Consensus statement: Palliative and supportive care in advanced heart failure. J Cardiac Failure 2004;3:200-9.
3. Rose EA, Gelijns AC, Moskowitz AJ, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345:1435-43.
4. Russell SD, Miller LW, Pagani FD. Advanced heart failure: a call to action. Congest Heart Fail 2008;14:316-21.
5. Lietz K, Miller LW. Improved survival of patients with end-stage heart failure listed for heart transplantation. Analysis of Organ Procurement and Transplantation Network/U.S. United Network of Organ Sharing Data, 1990 to 2005. J Am Coll Cardiol 2007;50:1282-90.
6. Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS annual report: 6,000 mechanical circulatory support patients. J Heart Lung Transplant 2013;32:141-56.
7. Jaski BE, Kim JC, Naftel DC, et al. Cardiac transplant outcome of patients supported on left ventricular assist device vs intravenous inotropic therapy. J Heart Lung Transplant 2001;20:449-56.
8. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulation support for inotropic-dependent heart failure who are not transplant candidates. J Am Coll Cardiol 2007;50:741-7.
9. Maybaum S, Mancini D, Xydas S, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD working group. Circulation 2007;115:2497-505.
10. Haddad M, Hendry PJ, Masters RG, et al. Ventricular assist devices as a bridge to cardiac transplantation: the Ottawa experience. Artif Organs 2004;28:136-41.
11. McKenna DH Jr, Eastlund T, Segall M, Noreen HJ, Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant 2002;21:1218-24.
12. Joyce DL, Southard RE, Torre-Amione G, Noon GP, Land GA, Loebe M. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant 2005;24:2054-9.
13. Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007;84:1556-63.
14. Irving C, Carter V, Parry G, Hasan A, Kirk R, Donor-specific HLA. antibodies in paediatric cardiac transplant recipients are associated with poor graft survival. Pediatr Transplant 2011;15:193-7.
15. Smith JD, Banner NR, Hamour IM, et al. De novo donors HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant 2011;11:312-9.
16. Rossano JW, Morales DL, Farhan Z, et al. Impact of antibodies against human leukocyte antigens on long-term outcome in pediatric heart transplant patients: an analysis of the United Network for Organ Sharing database. Thorac Cardiovasc Surg 2010;140:694-9.
17. Phelan PJ, O'Kelly P, O'Neill D, et al. Analysis of waiting times on Irish renal transplant list. Clin Transplant 2010;24:381-5.
18. Itescu S, John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg 2003;75(6 Suppl):S58-65.
19. Kirsch L, Timmermans T, Van Caenegem O, et al. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy. Eur J Cardiothoracic Surg 2008268-74.
20. Drakos SG, Kfoury AG, Kotter JR, et al. Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant 2009;28:838-42.
21. Arnaoutakis GJ, George TJ, Kilic A, et al. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. J Thorac Cardiovasc Surg 2011;142:1236-45.
22. Cotts WG, Johnson MR. The challenge of rejection and cardiac allograft vasculopathy. Heart Fail Reviews 2001;6:227-40.
23. Warner-Stevenson L. The evolving role of mechanical circulatory support in advanced heart failure. ISHLT Monograph Series I 2006:181-203.
24. Luo L, Sun Z, Cheng H, Lou G. Memory T-cell-specific therapeutics attenuate allograft rejection via mediation of alloreactivity in memory cells. Immunol Lett 2012;148:53-8.
25. Stehlik J, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report-2011. J Heart Lung Transplant 2011;30:1078-94.
26. Massad MG, McCarthy PM, Smedira NG, et al. Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? J Thorac Cardiovasc Surg 1996;112: 1275-83.
27. Tsau PH, Arabia FA, Toporoff B, Paramesh V, Sethi GK, Copeland JG. Positive panel reactive antibody titers in patients bridged to transplantation with a mechanical assist device. ASAIO J 1998;44:M634-7.
28. Bouma GJ, van Caubergh P, van Bree SP, et al. Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation 1996;62: 672-8.
29. Haynes L, Maue A. Effects of aging on T cell function. Curr Opin Immunol 2009;21:414-7.
30. Mahle WT, Berg AM, Kanter KR. Red blood cell transfusions in children awaiting heart transplant. Pediatr Trasnplant 2011;15: 728-32.
31. Kotter JR, Drakos SG, Horne BD, et al. Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proceedings 2010;42:2687-92.
32. Fernandez FG, Jaramillo A, Ewald G, et al. Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients. J Heart Lung Transplant 2005;24:S255-61.
33. Moazami N, Itescu S, Williams MR, Argenziano M, Weinberg A, Oz MC. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. J Heart Lung Transplant 1998;17:876-80.
34. Chih S, Ross HJ, McDonald MA, Isaac DL. Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J. Heart Lung 2012;31:780-2.
35. Yanagida R, Czer LSC, Reinsmoen NL, et al. Impact of virtual cross match on waiting times for heart transplantation. Ann Thorac Surg 2011;92:2104-11.
36. Alba AC, McDonald M, Rao V, Ross HJ, Delgado D. The effect of ventricular assist devices on long-term post-transplant outcomes: a systematic review of observational studies. Eur J Hear Failure 2011;13:785-95.
37. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011;57:1890-8.
38. Kumpati GS, Cook DJ, Blackstone EH, et al. HLA sensitization in ventricular assist device recipients: does type of device make a difference? J Thorac Cardiovasc Surg 2004;127:1800-7.
39. Gonzalez-Stawinski GV, Cook DJ, Chang AS, et al. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 2006;25:613-8.
40. Radovancevic B, Golino A, Vrtovec B, et al. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease? J Heart Lung Transplant 2005;24: 703-7.
41. Pamboukian SV, Costanzo MR, Dunlap S, et al. Relationship between bridging with ventricular assist device on rejection after heart transplantation. J Heart Lung Transplant 2005;24:310-5.
42. John R, Lietz K, Schuster M, et al. Immunologic sensitization in recipients of left ventricular assist devices. J Thoracic Cardiovasc Surg 2003;125:578-91.